home blog news careers français contact

Why so many US oncology drug developers have enhanced their clinical trial performance by leveraging Canada for successful study expansion.

The Reverse Feasibility Program™

A Novel CRO Approach to Site Selection
& Patient Recruitment

Reverse Feasibility Program for 50% faster site start-up.A revolutionary approach to feasibility assessment that accelerates study start-up by matching your protocol with the current study needs of motivated and pre-qualified North American sites.

How it works...

Oncology Clinical Trial News

Scimega launches Canadian expansion of a Phase I/II, Multicenter,Pharmacokinetic Guided Dose-Escalation and Dose-Confirmation Study of a Cytidine Deaminase Inhibitor (CDAi) in Subjects with Myelodysplastic Syndromes (MDS).

Scimega launches Canadian expansion of a Phase I/II, Multicenter Study to Evaluate the Safety and Efficacy of a novel, rationally designed, oncology drug candidate in Combination with nab-Paclitaxel (Abraxane®) and Gemcitabine in Patients with Metastatic Pancreatic Cancer.

Scimega launches Canadian expansion of an ongoing Phase 1 / 2 Study of an HSP90 Inhibitor Alone and in Combination with Crizotinib in the Treatment of Non-small Cell Lung Cancer.

Scimega launches Canadian expansion of an ongoing Phase 1b, open-label study to assess the safety and tolerability of an orally active, reversible and selective HER2 inhibitor combined with trastuzumab emtansine (TDM1) in HER2+metastatic breast cancer..

See all news...

Upcoming Scimega Events

ASCO 51st Annual Meeting

May 29 - June 4, 2015 in Chicago, IL

DIA 2015 – 51st Annual Meeting

June 14-18, 2015 in Washington, DC

Clinical Operations in Oncology Trials – East Coast

July 14-15, 2015 in Boston

See all upcoming events...

Latest Podcast

The Secret to Oncology Clinical Trial Performance

An Interview with Denise Deakin, President & Co-Founder of Scimega Oncology
Read podcast transcript...

Copyright © Scimega Research Inc. 2014. All rights reserved.
Privacy Policy

Oncology CRO   Clinical Trial Monitoring   Clinical Trial Management   Oncology Community